ATH 0.00% 0.5¢ alterity therapeutics limited

With half amount of Market Cap in hand, they do not have any...

  1. 405 Posts.
    lightbulb Created with Sketch. 38
    With half amount of Market Cap in hand, they do not have any excuse to delay the P2 study. Unless, they found something important that might lead to a higher possibility of P2 success. If it is the case, it is worthy to wait and be patient.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.